| |
property for sale in balchik varna brovets bansko bulgaria
News and Information Article
HOLLYWOOD, Fla., Feb. 1 // -- MAKO Surgical Corp., an emerging
orthopaedic medical technology company, presenting at the 2006 Florida Venture
Forum on February 1, in Ponte Vedra Beach, Florida, today announced a
comprehensive sponsored research plan and licensing arrangement with the
University of Florida (UF) whereby MAKO secured all rights in medical
applications to a low friction, ultra low wear rate polymer, referred to by
University scientists as "Material X." UF scientists believe that a component
made from this PEEK/PTFE nano composite material could prove significantly
more durable than other existing materials. While Material X has potential
applicability in many areas of medicine, MAKO, which is targeting various
stages of the $4 billion knee replacement surgery sector, anticipates
employing the material in the development of its unique knee implant and bone
resurfacing technologies for potentially dramatic results. A sponsored
research program is already underway to ensure that Material X is
biocompatible for humans and would provide the expected performance when used
as a bearing material for an orthopaedic joint replacement.
"We are encouraged by the early results of our research with UF and
excited about how this potentially game-changing material, when coupled with
our proprietary technology, will enable surgeons to advance standard surgical
approaches treating degenerative diseases of the knee," said MAKOs President
and CEO, Dr. Maurice R. Ferre. "Ultimately, Material X may be the ideal
complement to our Makoplasty(TM) therapy, whereby we will enable the delivery
of a joint implant through a keyhole incision, but also ensure the implant
itself will resist wear well beyond todays implant standards."
MAKOs proprietary solution, called Makoplasty(TM), targets degenerative
diseases of the knee and goes beyond traditional minimally invasive procedures
to enable rapid patient recovery and improved anatomical functionality. MAKOs
proprietary technology, the Haptic Guidance System(TM), enables surgeons to
digitally sculpt and preserve bone tissue through "keyhole" incisions in a
highly accurate, reproducible, yet simple and easy to learn manner.
"The University of Florida is pleased to expand our already substantial
research and commercial relationship with MAKO, a company recognized by the
Florida Venture Forum for high-growth potential," said David Day, Director of
the Office of Technology Licensing and Sid Martin Biotechnology Development
Incubator for the University. "Like MAKO, the University of Florida is driven
to develop unique solutions for the knee replacement market. Material X
should nicely complement MAKOs existing technologies in orthopaedic implant
design and surgical robotics, towards the ultimate goals of improved patient
outcome and enhanced quality of life."
About MAKO Surgical Corporation
MAKO Surgical Corp., located in Hollywood, Florida, is a privately-held
emerging orthopaedic medical device company developing advanced technologies
and solutions for the rapidly growing minimally invasive joint market. MAKO
is targeting the $4 billion worldwide knee surgery market. MAKOs proprietary
solution, called Makoplasty(TM), provides novel therapies for degenerative
diseases of the knee and goes beyond traditional minimally invasive procedures
to enable rapid patient recovery and improved anatomical functionality. MAKO
is committed to reducing pain, improving surgical approach and outcomes, and
restoring function and quality of life for millions of people worldwide. For
more information, please contact the company at info@makosurgical.com .
About University of Florida Office of Technology Licensing
The University of Floridas Office of Technology Licensing (OTL) is the
Universitys commercialization center. It receives almost 300 disclosures per
year generated from the cutting-edge research that takes place from all around
the campus. OTL has partnered with companies throughout Florida, the
Southeast and nationally to assist in the movement of technologies to the
marketplace and welcomes the opportunity to work with companies interested in
such a partnership. For more information, visit the website at
http://www.otl.uf.edu or email jmuir@ufl.edu.
CONTACTS:
Jeanette E. Levine David L. Day
MAKO Surgical Corp. University of Florida
2901 Simms Street 310 Walker Hall #115500
Hollywood, Fl 33020 Gainesville, FL 32611-5500
954-927-2044 352-392-8929
info@makosurgical.com dlday@ufl.edu
| |
|
|
 |
property for sale in balchik varna brovets bansko bulgaria |
|
|
|
|
|
|
|
|
|
Locations
